The Epigenetic Landscape of Promoter Genome-wide Analysis in Breast Cancer

RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells

(2016) A. Rasim Barutcu et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

A novel subtype classification and risk of breast cancer by histone modification profiling

(2016) Xiaohua Chen et al.   BREAST CANCER RESEARCH AND TREATMENT

H3K4 acetylation, H3K9 acetylation and H3K27 methylation in breast tumor molecular subtypes

(2016) Gaëlle Judes et al.   Epigenomics

Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model

(2016) Quan-Yi Zhao et al.   Clinical Epigenetics

Association of H3K9me3 and H3K27me3 repressive histone marks with breast cancer subtypes in the Nurses’ Health Study

(2014) Megan A. Healey et al.   BREAST CANCER RESEARCH AND TREATMENT

Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes

(2014) Yongsheng Li et al.   HUMAN MOLECULAR GENETICS

Expression of RUNX1 Correlates with Poor Patient Prognosis in Triple Negative Breast Cancer

(2014) Nicola Ferrari et al.   PLoS One

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

(2013) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Histone lysine trimethylation or acetylation can be modulated by phytoestrogen, estrogen or anti-HDAC in breast cancer cell lines

(2013) Aslihan Dagdemir et al.   Epigenomics

A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers

(2012) Rachael Natrajan et al.   JOURNAL OF PATHOLOGY

Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes

(2012) Karolina Holm et al.   Molecular Oncology

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Mutually exclusive expression of DLX2 and DLX5/6 is associated with the metastatic potential of the human breast cancer cell line MDA-MB-231

(2010) Monica Morini et al.   BMC CANCER

Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer

(2010) Katrina Bauer et al.   BMC CANCER

Runx1 Directly Promotes Proliferation of Hair Follicle Stem Cells and Epithelial Tumor Formation in Mouse Skin

(2010) C. S. L. Hoi et al.   MOLECULAR AND CELLULAR BIOLOGY

Deconstructing the molecular portraits of breast cancer

(2010) Aleix Prat et al.   Molecular Oncology

Identifying significant genetic regulatory networks in the prostate cancer from microarray data based on transcription factor analysis and conditional independency

(2009) Hsiang-Yuan Yeh et al.   BMC Medical Genomics

Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome

(2009) S. E. Elsheikh et al.   CANCER RESEARCH

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

(2009) Maggie C. U. Cheang et al.   JNCI-Journal of the National Cancer Institute

A Negative Feedback Regulatory Loop Associates the Tyrosine Kinase Receptor ERBB2 and the Transcription Factor GATA4 in Breast Cancer Cells

(2009) G. Hua et al.   MOLECULAR CANCER RESEARCH

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

(2009) Da Wei Huang et al.   Nature Protocols

Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment

(2009) Amy M. Dworkin et al.   SEMINARS IN CANCER BIOLOGY

Ethics of research on human biological materials

(2008) Laurence Lwoff   NATURE BIOTECHNOLOGY